The New Option in Low-Dose Oral Contraception
Subtitle: Expanding the Gestodene Choice (World Congress on Fertility and Sterility Proceeding)
Contributors: P. Lopes (Editor); S.R. Killick (Editor)
Publisher: Informa Healthcare
Published: March 15, 1996
Language: eng
Format: Hardcover
Number of pages: 70
ISBN-13: 9781850707394
Subjects: Birth control, contraception, family planning; Reproductive Medicine & Technology; Gynecology & Obstetrics; Contraception; Medical / Nursing; Physiological effect; Medical; Pharmacology; Medical / Reproductive Medicine & Technology; Congresses; Contraceptives, Oral; Ethinyl estradiol; Gestodene
First sentence: Reducing the estrogen dose in oral contraceptives to 20ug may offer advantages in terms of long-term safety and a reduction in the incidence of estrogen-related adverse events, but might theoretically lead to a reduced efficacy, poor cycle control or a loss of major non-contraceptive benefits.